Opaleye Management Inc. - Sep 14, 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
TARA
Transactions as of
Sep 14, 2022
Transactions value $
$93,808
Form type
4
Date filed
9/15/2022, 04:05 PM
Previous filing
Sep 15, 2022
Next filing
Sep 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock, par value $0.001 per share Purchase $56.1K +14.1K +0.55% $3.98 2.57M Sep 14, 2022 By Opaleye, L.P. F1
transaction TARA Common Stock, par value $0.001 per share Purchase $9.95K +2.5K +1.96% $3.98 130K Sep 14, 2022 By Managed Account F2
transaction TARA Common Stock, par value $0.001 per share Purchase $19K +5K +0.19% $3.80 2.58M Sep 15, 2022 By Opaleye, L.P. F1
transaction TARA Common Stock, par value $0.001 per share Purchase $8.74K +2.3K +1.77% $3.80 132K Sep 15, 2022 By Managed Account F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.